+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Proton Therapy Market in Switzerland, Reimbursement Policy, Patients Treated at Proton Facility & Forecast

  • ID: 4125929
  • Report
  • Region: Switzerland
  • 49 Pages
  • Renub Research
1 of 5
Switzerland Proton Therapy Market is Expected to Grow Thrice from its Present Market in 2016

Switzerland has one of the oldest proton therapy centers in Europe and was established in 1984 and there are so many recommended proton therapy patients from other parts of Europe coming for their treatment. The old proton therapy center at CPT, PSI, Villigen was further renovated with technological advancement in 2010 and again in 2013.

Switzerland Proton Therapy Market is expected to grow thrice from its present market in 2016. Rising cancer incidents and two advanced proton centers in planning stage is likely to boost the market of proton therapy in Switzerland during 2017 - 2021.
 
Proton Therapy Market in Switzerland, Reimbursement Policy, Patients Treated at Proton Facility & Forecast is a research report by Renub Research. This report studies the market in two parts a) Actual Market and b) Potential Market. The report also talks about the list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

a) Actual Market is the current market which is already present.
b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

Key Questions Answered in the Report:

  • What is the Proton Therapy Market in Switzerland & its growth potential in Future?
  • What is the Potential Proton Therapy Market in Switzerland and its Future?
  • How many Proton Therapy Facilities are operating in Switzerland?
  • How many Proton Therapy Facilities are going to open in near Future?
  • What is the number of people being treated in these Proton Therapy Centers yearly?
  • Is Proton Therapy Treatment being covered in the Reimbursement policy of Switzerland?
  • What are the sales of Proton Therapy Companies Globally (IBA, Varian, Elekta)?

Key Companies Covered:

  • IBA (Overview, Sales Analysis)
  • Varian Medical Systems (Overview, Sales Analysis)
  • Elekta (Overview, Sales Analysis)

Note: This report offers 10% free customization.
Note: Product cover images may vary from those shown
2 of 5

1. Executive Summary

2. Switzerland Proton Therapy Market - Actual & Potential Market
    2.1 Switzerland - Proton Therapy Market
    2.2 Switzerland - Potential Proton Therapy Market

3. Switzerland Proton Therapy Patient Number - Actual and Potential
    3.1 Switzerland - Patients Treated with Proton Therapy Actual Numbers & Forecast
    3.2 Switzerland - Patients with Proton Therapy Potential Numbers & Forecast

4. Switzerland - List of Proton Therapy Centers

5. Switzerland - Proton Therapy Treated Patients by Centers
    5.1 Villigen PSI (72 MeV-Optis) Proton Therapy Center
    5.2 Villigen PSI (230 MeV) Proton Therapy Center

6. Proton Therapy - Reimbursement Policies
    6.1 Proton Therapy Reimbursement Policies for Patients
    6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

7. Components of a Standard Proton Therapy Center
    7.1 Proton Accelerator
        7.1.1 Synchrotrons (example: LLUMC at Loma Linda)
        7.1.2 Cyclotrons (example: MGH Boston)
        7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
        7.1.4 Linacs (Rome)
        7.1.5 H-minus Synchrotrons
        7.1.6 Separated Sector Cyclotrons
        7.1.7 Super-conducting Cyclotrons
        7.1.8 Fast Cycling Synchrotron
    7.2 Beam Transport System
    7.3 Beam Delivery System
        7.3.1 The Passive Scattering Technique
        7.3.2 Beam Scanning
    7.4 Nozzle
        7.4.1 Single Scattering
        7.4.2 Double Scattering
        7.4.3 Uniform Scanning Nozzle
        7.4.4 Pencil Scanning Nozzle
    7.5 Treatment Planning System
    7.6 Image Viewers
    7.7 Patient Positioning System (PPS)
    7.8 Human Resource

8. Global Proton Therapy - Company Analysis (2010-2021)
    8.1 IBA Proton Therapy
        8.1.1 Sales Analysis
    8.2 Varian Medical Systems
        8.2.1 Sales Analysis
    8.3 Elekta
        8.3.1 Sales Analysis

9. Proton Therapy - Driving Factors
    9.1 Technology Advancement
    9.2 Growing Incidence of Cancer Patients in Switzerland

10. Proton Therapy - Challenges
    10.1 Requires Huge Investment
    10.2 Operations Challenges

List of Figures
Figure 1 1: Switzerland - Proton Therapy Market (Million US$), 2009 - 2016
Figure 1 2: Switzerland - Forecast for Proton Therapy Market (Million US$), 2017 - 2021
Figure 1 3: Switzerland - Potential Proton Therapy Market (Million US$), 2009 - 2016
Figure 1 4: Switzerland - Forecast for Potential Proton Therapy Market (Million US$), 2017 - 2021
Figure 2 1: Switzerland - Patient Treated with Proton Therapy (Number), 2009 - 2016
Figure 2 2: Switzerland - Forecast for Patient Treated with Proton Therapy (Number), 2017 - 2021
Figure 2 3: Switzerland - Potential Patient for Proton Therapy (Number), 2009 - 2016
Figure 2 4: Switzerland - Forecast for Potential Patient for Proton Therapy (Number), 2017 - 2021
Figure 7 1: Global - IBA Proton Therapy Sales (Million US$), 2010 - 2016
Figure 7 2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2017 - 2021
Figure 7 3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2010 - 2016
Figure 7 4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 - 2021
Figure 7 5: Global - Elekta Radiation Technology Sales (Million US$), 2010 - 2016
Figure 7 6: Global - Forecast for Elekta Radiation Technology Sales (Million US$), 2017 - 2021
Figure 8 1: Switzerland - Number of Patient Diagnosed With Cancer (Thousand), 2009 - 2016
Figure 8 2: Switzerland - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2017 - 2021

List of Tables
Table 3 1: Switzerland - Proton Therapy Facilities in Operation and in Development Phase
Table 4 1: Switzerland - Villigen PSI (72 MeV-Optis) Proton Therapy Center with Patients Treated (Number), 2008 - 2010
Table 4 2: Switzerland - Villigen PSI (230 MeV) Proton Therapy Center with Patients Treated (Number), 2008 - 2015

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Elekta (Overview, Sales Analysis)
  • IBA (Overview, Sales Analysis)
  • Varian Medical Systems (Overview, Sales Analysis)
Note: Product cover images may vary from those shown
5 of 5

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll